Rapid conversion of 2-D sketches and grayscale images into 3-D reliefs and organic textures, ideal for signet rings and intricate medallions.
Note: References to “Build 7349” appear in some user forums and download sources; Build 7336 is the more commonly documented version number. Version numbers may vary between releases and distribution channels.
MatrixGold is the official successor to Matrix 9. Developed by Gemvision, it merges the best features of Matrix and RhinoGold into a single, parametric interface. This allows you to alter design dimensions on the fly without restarting the model from scratch. 2. Rhinoceros 3D (with Jewelry Plugins) gemvision matrix 90 build 7349 x64rar link
Instead of risking your digital security with outdated, cracked files, consider transitioning to modern, officially supported jewelry design software. 1. MatrixGold
When Matrix 9.0 was released in 2017, the upgrade for existing Gemvision users was priced at $895, while new purchases cost $6,995. The substantial price point reflected the software‘s position as a professional-grade, industry-specific tool used by commercial jewelry designers and manufacturers. Rapid conversion of 2-D sketches and grayscale images
Interactive viewports allow for real-time shaping of standard jewelry profiles. V-Ray Rendering Engine Integration
Nevertheless, Matrix 9.0 remains relevant for users who: MatrixGold is the official successor to Matrix 9
Cracked software is one of the most common vectors for malware, ransomware, and viruses. When a user downloads an unofficial "x64rar" file, they have no way of knowing what is actually packaged inside. Cybercriminals often embed malicious code into these installers, which can lead to:
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.